Establishment of 6 pediatric rhabdomyosarcoma patient's derived xenograft models closely recapitulating patients' tumor characteristics.
Patrizia GaspariniMichela CasanovaGiovanni CentonzeCristina BorziLuca BergamaschiPaola ColliniAdele TestiStefano ChiaravalliMaura MassiminoGabriella SozziAndrea C FerrariMassimo MoroPublished in: Tumori (2022)
Our findings increase the number of available RMS PDX models and strengthen the role of PDXs as useful preclinical tools for patients with unmet medical needs and to develop personalized therapies.